BridgeBio Pharma Inc.

NASDAQ: BBIO · Real-Time Price · USD
35.45
1.20 (3.50%)
At close: Jun 02, 2025, 3:59 PM
34.77
-1.90%
After-hours: Jun 02, 2025, 05:16 PM EDT

BridgeBio Pharma Revenue Breakdown

Period Ending Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
License Revenue 65.92M 8M 13.8M
License Revenue Growth +724.04% -42.03% n/a
Product Revenue 3.79M n/a n/a
Product Revenue Growth n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selling, General, and Administrative Revenue 106.36M 94.78M 68.82M 59.52M 64.51M 47.58M 35.78M 36.12M 31.11M 31.86M 31.19M 36.43M 43.71M 54.75M 46.08M 45.97M 45.41M 37.44M 36.02M 37.97M 34.26M 34.97M 23.5M 16.92M 18.9M 14.38M 10.31M 10.89M 8.01M
Selling, General, and Administrative Revenue Growth +12.22% +37.73% +15.62% -7.73% +35.58% +33.00% -0.96% +16.12% -2.37% +2.16% -14.38% -16.67% -20.16% +18.80% +0.25% +1.24% +21.29% +3.95% -5.14% +10.82% -2.03% +48.85% +38.88% -10.48% +31.42% +39.51% -5.35% +36.02% n/a
Research and Development Revenue 111.43M 130.35M 120.44M 114.69M 140.97M 130.23M 125.14M 108.09M 93.51M 91.55M 92.51M 108.4M 107.65M 123.75M 104.31M 102.07M 122.56M 90.17M 92.05M 86.6M 68.22M 57.48M 55.28M 52.33M 44.85M 51.2M 31.15M 23.89M 33.83M
Research and Development Revenue Growth -14.51% +8.22% +5.01% -18.64% +8.25% +4.07% +15.77% +15.59% +2.14% -1.04% -14.66% +0.70% -13.01% +18.64% +2.19% -16.72% +35.91% -2.04% +6.30% +26.93% +18.68% +3.99% +5.63% +16.67% -12.40% +64.38% +30.37% -29.38% n/a